FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313010096> ?p ?o ?g. }

• W2313010096 endingPage "331" @default.
• W2313010096 startingPage "326" @default.
• W2313010096 abstract "Objectives: We have previously shown that refractory neuroendocrine tumors can respond to moderate doses of chemoradiotherapy. We completed a dose-escalation phase I/II trial combining hepatic arterial (HA) chemotherapy, chemoembolization, and dose-escalated whole liver radiotherapy to determine the maximum safe dose of radiation that could be delivered and to make a preliminary assessment of response. Materials and Methods: From 2002 to 2009, 19 patients with symptomatic neuroendocrine liver metastases who failed somatostatin analog therapy were enrolled. HA fluorodeoxyuridine, leucovorin, and streptozotocin were delivered, as concurrent whole liver radiotherapy was dose escalated from 24 to 32 Gy in 2 Gy fractions, with a target rate of dose-limiting grade ≥3 radiation-induced liver disease of 10%. Eight weeks later, for patients without grade ≥3 liver or grade ≥4 any toxicity, a 72-hour infusion of HA fluorodeoxyuridine and leucovorin was given, followed by transarterial chemoembolization. Results: Eleven patients completed the entire protocol and received 24 to 32 Gy. No patients developed radiation-induced liver disease; 7 had grade 3 to 4 transiently increased liver function tests, and 4 had other grade 4 toxicities. Three patients (14%) had partial response, 16 (84%) stable disease. Median freedom from local progression and overall survival were 35.3 and 54.6 months, respectively. Conclusions: Thirty-two in 2 Gy daily fractions can be delivered safely when combined with HA chemotherapy and subsequent transarterial chemoembolization. However, although objective responses were observed, this combination was not significantly better than our prior approaches. Further treatment intensification strategies, including individualized dose escalation for radiation-tolerant livers, and improved radiosensitization should be investigated, along with improved systemic therapy." @default.
• W2313010096 created "2016-06-24" @default.
• W2313010096 creator A5008097242 @default.
• W2313010096 creator A5032791667 @default.
• W2313010096 creator A5046132413 @default.
• W2313010096 creator A5060316016 @default.
• W2313010096 creator A5061377078 @default.
• W2313010096 creator A5067078236 @default.
• W2313010096 creator A5075661070 @default.
• W2313010096 creator A5078503895 @default.
• W2313010096 creator A5082916383 @default.
• W2313010096 date "2018-04-01" @default.
• W2313010096 modified "2023-10-16" @default.
• W2313010096 title "Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases" @default.
• W2313010096 cites W1990509102 @default.
• W2313010096 cites W1995907539 @default.
• W2313010096 cites W2050884534 @default.
• W2313010096 cites W2062785452 @default.
• W2313010096 cites W2069506836 @default.
• W2313010096 cites W2071250178 @default.
• W2313010096 cites W2076108528 @default.
• W2313010096 cites W2080519663 @default.
• W2313010096 cites W2086241921 @default.
• W2313010096 cites W2090483604 @default.
• W2313010096 cites W2110922803 @default.
• W2313010096 cites W2115686439 @default.
• W2313010096 cites W2120851351 @default.
• W2313010096 cites W2123942027 @default.
• W2313010096 cites W2137142564 @default.
• W2313010096 cites W2137855860 @default.
• W2313010096 cites W2138270420 @default.
• W2313010096 cites W2141467520 @default.
• W2313010096 cites W2143842256 @default.
• W2313010096 cites W2158474413 @default.
• W2313010096 cites W2167228337 @default.
• W2313010096 cites W2325704081 @default.
• W2313010096 doi "https://doi.org/10.1097/coc.0000000000000276" @default.
• W2313010096 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4985493" @default.
• W2313010096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26886946" @default.
• W2313010096 hasPublicationYear "2018" @default.
• W2313010096 type Work @default.
• W2313010096 sameAs 2313010096 @default.
• W2313010096 citedByCount "1" @default.
• W2313010096 countsByYear W23130100962017 @default.
• W2313010096 crossrefType "journal-article" @default.
• W2313010096 hasAuthorship W2313010096A5008097242 @default.
• W2313010096 hasAuthorship W2313010096A5032791667 @default.
• W2313010096 hasAuthorship W2313010096A5046132413 @default.
• W2313010096 hasAuthorship W2313010096A5060316016 @default.
• W2313010096 hasAuthorship W2313010096A5061377078 @default.
• W2313010096 hasAuthorship W2313010096A5067078236 @default.
• W2313010096 hasAuthorship W2313010096A5075661070 @default.
• W2313010096 hasAuthorship W2313010096A5078503895 @default.
• W2313010096 hasAuthorship W2313010096A5082916383 @default.
• W2313010096 hasBestOaLocation W23130100962 @default.
• W2313010096 hasConcept C126322002 @default.
• W2313010096 hasConcept C2776694085 @default.
• W2313010096 hasConcept C2989005 @default.
• W2313010096 hasConcept C2992208098 @default.
• W2313010096 hasConcept C509974204 @default.
• W2313010096 hasConcept C71924100 @default.
• W2313010096 hasConcept C90924648 @default.
• W2313010096 hasConceptScore W2313010096C126322002 @default.
• W2313010096 hasConceptScore W2313010096C2776694085 @default.
• W2313010096 hasConceptScore W2313010096C2989005 @default.
• W2313010096 hasConceptScore W2313010096C2992208098 @default.
• W2313010096 hasConceptScore W2313010096C509974204 @default.
• W2313010096 hasConceptScore W2313010096C71924100 @default.
• W2313010096 hasConceptScore W2313010096C90924648 @default.
• W2313010096 hasIssue "4" @default.
• W2313010096 hasLocation W23130100961 @default.
• W2313010096 hasLocation W23130100962 @default.
• W2313010096 hasLocation W23130100963 @default.
• W2313010096 hasLocation W23130100964 @default.
• W2313010096 hasOpenAccess W2313010096 @default.
• W2313010096 hasPrimaryLocation W23130100961 @default.
• W2313010096 hasRelatedWork W1981900821 @default.
• W2313010096 hasRelatedWork W2089609493 @default.
• W2313010096 hasRelatedWork W2347438058 @default.
• W2313010096 hasRelatedWork W2349204430 @default.
• W2313010096 hasRelatedWork W2353276349 @default.
• W2313010096 hasRelatedWork W2384708512 @default.
• W2313010096 hasRelatedWork W2387970634 @default.
• W2313010096 hasRelatedWork W2417555288 @default.
• W2313010096 hasRelatedWork W3030219380 @default.
• W2313010096 hasRelatedWork W3211657369 @default.
• W2313010096 hasVolume "41" @default.
• W2313010096 isParatext "false" @default.
• W2313010096 isRetracted "false" @default.
• W2313010096 magId "2313010096" @default.
• W2313010096 workType "article" @default.